Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Biobanking has long generated a host of challenging ethical and legal issues, particularly in relation to consent. A topic at the heart of current debates is the acceptability of the use of 'broad' consent in place of more specific and conventional consent approaches. In this paper, the justifications for the move toward broad consent are analysed and critiqued. It is concluded that all of the justifications - such as concern for costs, the desire to do research in the public good and the concept of minimal risk - remain contentious and seem insufficient, at least on their own, to stand as a rationale for a move away from traditional notions of consent. © 2009 A B Academic Publishers.

Original publication




Journal article


Medical Law International

Publication Date





85 - 100